To investigate whether hydroxylated metabolites of benzene may be responsible for the amplification of granulocyte-macrophage progenitor cells (GM-CFC) observed in mice that inhale benzene, groups of six C57BL6 mice were injected with hydroquinone (HQ) (75 mg/kg) or HQ (50 mg/kg) plus phenol (PHE) (50 mg/kg) twice daily for 11 days. Deviations in blood leukocyte and erythrocyte levels by up to one-third were noted in the treated groups; however, the peripheral blood differential counts were unchanged. Although no changes in bone marrow cellularity were observed in mice treated with HQ, cellularity was decreased by a factor of two in the mice that had received HQ plus PHE. The number of GM-CFC per femur was doubled in both treated groups. In vitro experiments using the murine multipotent hematopoietic progenitor cells FDCP mix also showed a duplication of GM-CFC formation in the presence of HQ at concentrations between 106 M and 10-10 M. When HQ and PHE were present at equimolar concentrations, significantly increased colony formation was still observed with 10-12 M of metabolites. The effect was independent of the concentration of GM-colony-stimulating factor used. We suggest that HQ is a major mediator of the stimulatory effect of benzene on GM-CFC in mice. In addition, the in vitro data indicate that a direct effect on GM-CFC is involved. -Environ Health Perspect 104(Suppl 6): 1271-1274 (1996) 
Introduction
Benzene has been well recognized as a hazardous industrial chemical for many years (1) . Exposure to benzene has been associated with increased incidence of blood dyscrasias, including cytopenias, aplastic anemias, myelodysplastic syndromes, and leukemias (2) (3) (4) . Damage to the hematopoietic system by benzene has been predominantly linked to the formation and accumulation in bone marrow of hydroxylated derivatives such as hydroquinone (HQ) and catechol (5, 6) . This was shown to be due to the conversion of phenol (PHE), the major in vivo metabolite of benzene, by myeloid cell-derived myeloperoxidase in the bone marrow (7) . Oxidation of HQ to p-benzoquinone (BQ) via a semiquinone intermediate is considered a key step towards the generation of toxic intermediates in bone marrow (8) ; however, open-ring products such as trans-transmucondialdehyde may also be responsible for cytotoxic damage following benzene exposure (9, 10) .
Types of permanent DNA damage caused by benzene or its metabolites include structural chromosome aberrations, aneuploidy, sister chromatid exchange, micronuclei (11) , and gene mutations (12) . Hydroquinone and BQ have been shown to result in the formation of DNA adducts, whose structures have been characterized in part (13) . Other studies have looked at short-term effects of hydroxylated benzene metabolites on different cellular compartments of bone marrow, i.e., different types of stroma cells, hematopoietic stem cells, progenitor cells, and maturing cells of different blood cell lineages. Mainly, marrow-adherent cells, including mononuclear phagocytes, have been defined as targets of hematopoietic damage by benzene (14) (15) (16) (17) .
Benzene application augments precursor cells of granulocyte-macrophage (GM) lineage in bone marrow of mice during and after chronic inhalation (18 We investigated whether HQ administered in vivo could reproduce the increase in GM-CFC seen in mice that inhaled benzene chronically (18) . We used the protocol that had been reported by Eastmond et al. (20) Effect of Hydroquinone on Formation of Granulocyte-Macrophage Colonies in Vtro When HQ was present at noncytotoxic concentrations, the number of GM colonies formed by FDCP-mix cells was enhanced about 2-fold, if either GM-CSF or IL-3 was used as the cytokine driving colony growth (Figure 2A,B) . When PHE was present at equimolar concentrations in addition to HQ, a left shift of the dose-response curve of HQ by 2 to 3 logs was observed ( Figure  2C ). Addition of PHE to HQ-containing cultures did not result in toxicity at concentrations as high as 106M. Variation of GM-colony stimulating factor (CSF) concentrations at constant levels of HQ did not affect the ability of HQ to elicit enhanced colony formation at both plateau and also non-saturating cytokine concentrations ( Figure 3 ). This suggests synergistic interaction of HQ and PHE with either GM-CSF or IL-3.
Discussion
We observed an increase in total GM-CFC in the bone marrow of mice treated with HQ or an equimolar mixture of HQ and PHE. Snyder et al (18) Irons et al. (19) also contain substantial numbers of multipotential precursors in addition to GM-CFC, it is possible that HQ and GM-CSF act on a multipotential precursor of GM-CFCs rather than on GM-CFCs themselves. They may induce these "pre-GM-CFCs" to undergo extra cell divisions to yield increased numbers of GM-CFC. Another possibility is that HQ and GM-CSF counteract, for example, an apoptotic mechanism that normally results in cell death of a proportion of potential colony-forming cells. Additional work will be necessary to elucidate the mechanisms underlying the synergism between hematopoietic growth factors and benzene metabolites.
